Tissue engineering

Tissue engineering can perhaps be best defined as the use of a combination of cellss, engineering materials, and suitable biochemical factors to improve or replace biological functions in an effort to effect the advancement of medicine. MacArthur and Oreffo (as cited in "References") defined tissue engineering as "understanding the principles of tissue growth, and applying this to produce functional replacement tissue for clinical use." Probably the first definition of tissue engineering was by Langer and Vacanti who stated it to be "an interdisciplinary field that applies the principles of engineering and life sciences toward the development of biological substitutes that restore, maintain, or improve tissue function”.

In 2003, the NSF published a report titled "The Emergence of Tissue Engineering as a Research Field", which gives a thorough description of the history of this field.

A typical tissue engineering solution consists of a number of parts as alluded to above. This article will discuss each part in turn, along with its implications.

Cells

Tissue engineering solves problems by using living cells as engineering materials. These could be artifical skin that includes living fibroblasts, cartilage repaired with living chondrocytes, or other types of cells used in other ways.

Cells became available as engineering materials when scientists at Geron Corp. discovered how to extend telomeres in 1998. Before this, laboratory cultures of healthy, noncancerous mammalian cells would only divide a fixed number of times, up to the Hayflick limit.

The cells are often categorized by their source. "Autologous" cells come from the same body as that to which they will be reimplanted. "Allogenic" cells come from another body. "Xenogenic" cells come from another species.

Autologous cells have the fewest problems with rejection and pathogen transmission—however in genetic disease, suitable autologous cells are not available. In severe burns, autologous cells will not be available in sufficient quantities. Autologous cells also must be cultured from samples before they can be used. This takes time, so autologous solutions are not very quick.

For more information upon the sources of cells see this article on cell selection for tissue engineering.

Engineering materials

Cells as found above are generally implanted, or 'seeded' into a scaffold material which serves at least one of the following purposes:

Enhances structural properties

Delivers biochemical factors

Delivers or allows delivery of vital cell nutrients

Exerts certain mechanical and biological influences to modify the behaviour of the cell phase

Many different materials (natural and synthetic, biodegradable and permanent) have been investigated.
A commonly used material is PLA - poly lactic acid. This is a material which degrades within the human body to form lactic acid, a naturally occurring chemical which is easily removed from the body. This means that during the time that cells are fabricating their own natural matrix structure around themselves, the PLA is able to provide structural integrity within the body, and eventually it will break down, leaving the neotissue (newly formed tissue which will take over the mechanical load).

External links

Tissue engineering

Pittsburgh Tissue Engineering Initiative

Tissue Engineering Pages

Agencies that Support Tissue Engineering Research

National Institutes of Health

National Science Foundation

References

Langer, R & Vacanti JP, Tissue Enginering, Science 260(5110), 920-6, 1993 (more than 1000 quotations!)

MacArthur, B. D. & Oreffo, R. O. C. (6 January 2005). Bridging the gap. In Nature, 433, 19.

http://www.nsf.gov/pubs/2004/nsf0450/start.htm "The Emergence of Tissue Engineering as a Research Field"

NodeWorks boosts web surfing!

Page Returned in 0.429 seconds - HTML Compressed 67.0%

This article is from Wikipedia. All text is available
under the terms of the GNU Free Documentation License.